Hypofractionated Concomitant Chemoradiation in Inoperable Locally Advanced Non-small Cell Lung Cancer: A Report on 100 Patients and a Systematic Review-Reference-Cited by-同舟云学术

Hypofractionated Concomitant Chemoradiation in Inoperable Locally Advanced Non-small Cell Lung Cancer: A Report on 100 Patients and a Systematic Review

Published:2019-02 Issue:2 Volume:31 Page:e1-e10
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Iqbal M.S.,Vashisht G.,McMenemin R.,Atherton P.,McDonald F.,Simmons T.,Bradshaw A.,Kovarik J.,Turnbull H.,Dodd L.,Mulvenna P.,Greystoke A.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference21 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

3. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients

4. Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: results from 4 UK centres;Din;Radiother Oncol,2013

5. SOCCAR: a randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III non-small cell lung cancer and good performance status;Maguire;Eur J Cancer,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 2. Lung (non-small cell lung cancer);Radiation Oncology Journal;2024-06-30

2. Randomized, Multicenter, Phase 3 Study of Accelerated Fraction Radiation Therapy With Concomitant Boost to the Gross Tumor Volume Compared With Conventional Fractionation in Concurrent Chemoradiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: The Korean Radiation Oncology Group 09-03 Trial;International Journal of Radiation Oncology*Biology*Physics;2023-03

3. Excessive esophageal toxicity in patients with locally advanced non-small cell lung cancer treated with concurrent hypofractionated chemoradiotherapy and 3-weekly platinum doublet chemotherapy;Clinical and Translational Radiation Oncology;2022-09

4. Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the ‘radio talk’ webinars;Expert Review of Anticancer Therapy;2022-04-25

5. GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer;World Journal of Clinical Oncology;2022-04-24